Van de Velde H, De Vos A, Sermon K, Staessen C, De Rycke M, Van Assche E, Lissens W, Vandervorst M, Van Ranst H, Liebaers I, Van Steirteghem A (2000) Embryo implantation after biopsy of one or two cells from cleavage-stage embryos with a view to preimplantation genetic diagnosis. Prenat Diagn 20, 1030-1031.

Tournaye H (2000) Management of male infertility by assisted reproductive technologies. Baillieres Best Pract Res Clin Endocrinol Metab 14, 423-421.

Van den Abbeel E, Camus M, Joris H, Van Steirteghem A (2000) Embryo freezing after intracytoplasmic sperm injection. Mol Cell Endocrinol 169, 49-41.

Sermon K, Henderix P, Lissens W, De Vos A, Vandervorst M, Vanderfaeillie A, Vamos E, Van Steirteghem A, Liebaers I (2000) Preimplantation genetic diagnosis for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. Mol Hum Reprod 6, 1165-1161.

Manning M, Lissens W, Bonduelle M, Camus M, De Rijcke M, Liebaers I, Van Steirteghem A (2000) Study of DNA-methylation patterns at chromosome 15q11-q13 in children born after ICSI reveals no imprinting defects. Mol Hum Reprod 6, 1049-1041.

De Vos A, Sermon K, Van de Velde H, Joris H, Vandervorst M, Lissens W, De Paepe A, Liebaers I, Van Steirteghem A (2000) Two pregnancies after preimplantation genetic diagnosis for osteogenesis imperfecta type I and type IV. Hum Genet 106, 605-601.

Nogueira D, Staessen C, Van de Velde H, Van Steirteghem A (2000) Nuclear status and cytogenetics of embryos derived from in vitro-matured oocytes. Fertil Steril 74, 295-291.

Goossens V, Sermon K, Lissens W, Vandervorst M, Vanderfaeillie A, De Rijcke M, De Vos A, Henderix P, Van De Velde H, Van Steirteghem A, Liebaers I (2000) Clinical application of preimplantation genetic diagnosis for cystic fibrosis. Prenat Diagn 20, 571-571.

Silber SJ, Johnson L, Verheyen G, Van Steirteghem A (2000) Round spermatid injection. Fertil Steril 73, 897-891.

De Vos A, Van Steirteghem A (2000) Zona hardening, zona drilling and assisted hatching: new achievements in assisted reproduction. Cells Tissues Organs 166, 220-221.

Van Den Abbeel E, Van Steirteghem A (2000) Zona pellucida damage to human embryos after cryopreservation and the consequences for their blastomere survival and in-vitro viability. Hum Reprod 15, 373-371.

Vegetti W, Van Assche E, Frias A, Verheyen G, Bianchi MM, Bonduelle M, Liebaers I, Van Steirteghem A (2000) Correlation between semen parameters and sperm aneuploidy rates investigated by fluorescence in-situ hybridization in infertile men. Hum Reprod 15, 351-351.

Adashi EY, Cohen J, Hamberger L, Jones HW Jr, de Kretser DM, Lunenfeld B, Rosenwaks Z, Van Steirteghem A (2000) Public perception on infertility and its treatment: an international survey. The Bertarelli Foundation Scientific Board. Hum Reprod 15, 330-331.

Ludwig M, Felberbaum RE, Devroey P, Albano C, Riethmuller-Winzen H, Schuler A, Engel W, Diedrich K (2000) Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 264, 29-21.

Posaci C, Smitz J, Camus M, Osmanagaoglu K, Devroey P (2000) Progesterone for the luteal support of assisted reproductive technologies: clinical options. Hum Reprod 15 Suppl 1, 129-121.

Roman E, Aytoz A, Smitz JE, Faguer B, Camus M, Van Steirteghem AC, Devroey P (2000) Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. Hum Reprod 15, 1435-1431.

Platteau P, Vandervorst M, Devroey P (2000) Long term follow-up of children born after inadvertent administration of a GnRH-analogue in early pregnancy. Hum Reprod 15, 1421.

Felberbaum RE, Albano C, Ludwig M, Riethmuller-Winzen H, Grigat M, Devroey P, Diedrich K (2000) Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 15, 1015-1011.

Tavaniotou A, Smitz J, Bourgain C, Devroey P (2000) Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update 6, 139-131.

Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P (2000) Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 15, 526-521.

Baetens P, Devroey P, Camus M, Van Steirteghem AC, Ponjaert-Kristoffersen I (2000) Counselling couples and donors for oocyte donation: the decision to use either known or anonymous oocytes. Hum Reprod 15, 476-471.

Devroey P (2000) GnRH antagonists. Fertil Steril 73, 15-11.

Tournaye H (2000) Storing reproduction for oncological patients: some points for discussion. Mol Cell Endocrinol 169, 133-131.

Vandervors M, Staessen C, Sermon K, De Vos A, Van de Velde H, Van Assche E, Bonduelle M, Vanderfaellie A, Lissens W, Tournaye H, Devroey P, Van Steirteghem A, Liebaers I (2000) The Brussels' experience of more than 5 years of clinical preimplantation genetic diagnosis. Hum Reprod Update 6, 364-361.

Schats R, Sutter PD, Bassil S, Kremer JA, Tournaye H, Donnez J (2000) Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group. Hum Reprod 15, 1691-1691.

Van Landuyt L, Lissens W, Stouffs K, Tournaye H, Liebaers I, Van Steirteghem A (2000) Validation of a simple Yq deletion screening programme in an ICSI candidate population. Mol Hum Reprod 6, 291-291.